HOOK Stock Summary and Trading Ideas (Hookipa Pharma | NASDAQ:HOOK)

HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

Hookipa Pharma trades on the NASDAQ stock market under the symbol HOOK.

As of January 31, 2025, HOOK stock price declined to $1.96 with 32,040 million shares trading.

HOOK has a beta of 1.21, meaning it tends to be more sensitive to market movements. HOOK has a correlation of 0.04 to the broad based SPY ETF.

HOOK has a market cap of $23.63 million. This is considered a Sub-Micro Cap stock.

Last quarter Hookipa Pharma reported $5 million in Revenue and -$1.10 earnings per share. This fell short of revenue expectation by $-2 million and exceeded earnings estimates by $.18.

In the last 3 years, HOOK traded as high as $30.50 and as low as $1.72.

The top ETF exchange traded funds that HOOK belongs to (by Net Assets): VTI, VXF, DFAC, DFAS, DFAT.

HOOK has underperformed the market in the last year with a price return of -68.4% while the SPY ETF gained +26.1%. HOOK has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -48.3% and +0.5%, respectively, while the SPY returned +6.2% and +0.7%, respectively.

HOOK support price is $1.86 and resistance is $2.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HOOK shares will trade within this expected range on the day.